PMID: 16527004Mar 11, 2006Paper

Review of adherence to medications for the treatment of osteoporosis

Current Osteoporosis Reports
Deborah T Gold, Stuart L Silverman

Abstract

One of the major challenges of successful osteoporosis management is poor patient adherence to current therapies. Individuals who are nonadherent have significant consequences of reduced bone mineral density response, reduced bone marker suppression, and increased risk for fracture compared with individuals who are adherent. Although reducing the dosing interval from daily to weekly oral bisphosphonates has improved adherence, adherence with weekly bisphosphonates remains suboptimal. Barriers to adherence include patient health beliefs, inadequate patient education and age. Potential solutions include increased health care provider-patient interaction, and longer times between doses of medications.

References

Feb 17, 1997·The American Journal of Medicine·N H Miller
Sep 26, 1997·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·B BenderC Rand
Dec 4, 1992·Medical Care Review·M K O'BrienJ Raeburn
Feb 1, 2002·International Journal of Epidemiology·J T Hart
May 6, 2003·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·B HamiltonH Taggart
Sep 2, 2003·The American Journal of Medicine·Anna N A TostesonBruce Ettinger
Sep 25, 2003·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·Robert A YoodEva Lydick
Oct 3, 2003·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·Alexandra PapaioannouCharlie H Goldsmith
May 29, 2004·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J Jaime CaroChristel Naujoks
Mar 4, 2005·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·Cynthia S Pickney, Jon A Arnason
Aug 5, 2005·The New England Journal of Medicine·Lars Osterberg, Terrence Blaschke
Oct 4, 2005·Current Medical Research and Opinion·Joyce A CramerRoy Altman
Nov 1, 2005·The American Journal of Geriatric Pharmacotherapy·Mary T Roth, Jena L Ivey
Nov 17, 2005·Archives of Internal Medicine·Daniel H SolomonM Alan Brookhart

❮ Previous
Next ❯

Citations

Mar 21, 2008·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J A SunyeczM M Amonkar
Jun 4, 2008·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·O StrömB Jönsson
Dec 8, 2009·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·I ImazJ M Amate
Mar 17, 2010·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·R OtmarJ A Pasco
Jun 1, 2011·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·V BreuilE Legrand
Sep 29, 2011·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J A KanisC Cooper
Apr 13, 2013·Clinical Medicine & Research·Sharon J RolnickRichard J Bruzek
Mar 2, 2013·Journal of Pharmaceutical Sciences·Xiaoming XuMansoor A Khan
Dec 7, 2007·Mayo Clinic Proceedings·Prajesh KothawalaR J Halbert
May 25, 2013·Endocrinology and Metabolism Clinics of North America·Dima L Diab, Nelson B Watts
May 28, 2011·The American Journal of Geriatric Pharmacotherapy·Leslie Jackson ConwellMartin Marciniak
Nov 4, 2008·Patient Education and Counseling·Lora GiangregorioJ D Adachi
Jul 27, 2012·Annals of the New York Academy of Sciences·Carsten GoesslRachel B Wagman
Feb 21, 2009·The American Journal of Medicine·Ethel S SirisStuart L Silverman
Jan 31, 2013·Medical Anthropology Quarterly·Ruth Prince
Aug 8, 2019·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·M HiligsmannJ Y Reginster
Oct 24, 2013·Current Opinion in Endocrinology, Diabetes, and Obesity·Dima L Diab, Nelson B Watts
Jul 16, 2008·Southern Medical Journal·Mark G Martens, Howard Shaw
Sep 6, 2020·Archives of Osteoporosis·Madeline S Wilton-ClarkEmma O Billington
Jun 8, 2021·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·A J SingerA Yehoshua
May 24, 2021·Endocrinology and Metabolism Clinics of North America·Dima L Diab, Nelson B Watts

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
M RossiniTreatment of Osteoporosis in clinical Practice (TOP) Study Group
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
D WeyckerG Oster
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
F LekkerkerkerGroup for the Respect of Ethics and Excellence in Science (GREES)
© 2021 Meta ULC. All rights reserved